The Decline Of The Pharmaceutical Stock Market Is Hard To Change &Nbsp;

600572.SH, who has always been single in the collapse of the entire pharmaceutical sector, is still showing a strong side in the continuing destruction of the market.

From April 19th, the market continued to plummet, and the Shanghai composite index plunged 10.77% in just 32 trading days.

In the same period, not only did there not be a sustained decline, but after the resumption of power, it gained a 26.73% increase.

The strength of Kang Bei Bei was quite obvious in late May 27th.

Despite the fact that at the end of the day, at one time, he was firmly put to death on the limit board, but what was interesting was that in the last two minutes before the closing session, more than 70 shares on the limit board were swallowed up by a mysterious fund.

Moreover, in order to avoid the fate of being knocked down again, the purchase price of nearly 2 million 300 thousand shares was quickly underneath the closing price of 12.30 yuan.

Eventually, he closed at 8.82%.

What is even more striking is that only after a trading day, in May 31st, he was quickly sealed off on the trading board.

Under the weak market, it is also a medical sector that everyone can avoid. Why is it that the strong and persistent Kang Bei Bei is only favored by funds?

Where is the mysterious fund from?

"Evil stock"

It is also hard to get rid of the evil spirits of the big market.

After the elimination of power, along with the collapse of the market, he was repeatedly pushed to the limit of the limit. Only after the ex rights, did he lose 4 times more than 7%.

However, despite repeated plummeting, up to 3 time limit performance in the same period still makes it difficult for the market to deny it.

In fact, from November 30th last year, the pharmaceutical stocks plunged in the market, is still one of the few pieces of the plate survived.

On the eve of the tumble of the big round, there were amazing performances.

In May 17th, the company just went through a trading limit. In the three consecutive trading days that began in May 17th, it was a 23.58% increase.

On the eve of the elimination of power in April 25th this year, he also had similar madness in the two tier market.

After publishing a quarterly report in April 15th, the price of Kang's shell jumped to a high level of 27.55 yuan from 21.59 yuan.

For 5 consecutive trading days, the increase was as high as 27.61%.

If the price is calculated at around 28.40 yuan, the newspaper reporter found that since last November 30th, the stock price of not only has not declined, but it has gained more than 38%.

In contrast to the strong performance of Kang Bei Bei, the performance of the entire pharmaceutical sector is still continuing to languish.

According to relevant data, the once strong pharmaceutical stocks, after reaching the peak of 4600.77 in November 29, 2010, fell into the mire of continuous decline.

According to the latest data, the medical share index fell more than 21% in six months.

What is more worrying is that such a decline is not stable.

Beginning in May 23rd, the index of medicine stocks was in existence.

"No matter it is compared with the pharmaceutical sector or compared with the market, the trend of Kang Bei is pretty good. Now the problem is that the collapse of the market will form a certain pressure on it, and there may be a possibility of making up."

Private sector analysis of a pharmaceutical sector in Shanghai.

The concerns of the private sector are not unreasonable.

Although in May 25th, when the market and the pharmaceutical sector both fell, it continued to rise by 5.47%.

However, according to the data of big intelligence super win, 4 main trading days since May 23rd, the main funds of COM have shown a net outflow.

Even on the day of the May 25th surge, the large and super family funds of the company were still net outflows, with a net outflow of more than 18 million yuan.

On the day of the crash in May 27th, the net outflow of large and super large households exceeded 25 million yuan.

However, oddly enough, even in the context of the recent turmoil in the market, it has continued to rise, with a cumulative increase of 15.77% a week.

Three benefits to help private equity do more?

Behind the upbeat performance of the market, it is difficult to find public funds in the latest ten major shareholders of circulation.

A quarterly report shows that the company's top ten tradable shares are only a 1 million 919 thousand and 700 year long shareholding Dynamic Strategy Fund.

In addition, the list of the top ten tradable shares of Kang Bei Bei has two institutional investors, namely, Sino fusion International Trust - Fusion new 297 and China Foreign Economic and Trade Trust - Fujin 7.

Related information shows that Rongxin No. 297 is a fund for YOUNGOR's private investment management of sunshine private Kay stone, and its fund manager is Cheng Junhao.

Fujin 7 is another product of the sunshine private placement fund, which is the general manager of the private placement company.

It is worth noting that as of the end of 2010, the two largest public offering institutions in the top ten tradable shares of Kun bay were all GF products, namely, gf's mixed fund and GF strategy.

The two funds hold 10 million shares and 6 million 999 thousand and 700 shares respectively, which means that the amount of the 17 million funds held by the two funds is only about 17 million shares.

But in the first quarter of the year, both of the two funds disappeared from the top ten list of tradable shares.

Among the top ten tradable shares in the quarterly report, excluding the top two of the group and the Chongqing venture capital, the other 8 shareholders of the company have only 20 million 642 thousand shares.

With the collapse of the pharmaceutical sector and the massive withdrawal of public offerings, he could still stand up and had to look at all kinds of investors.

"Last year to the end of January 25th this year also fell a lot, in fact, mainly rely on the rebound in January 25th, plus the recent elimination of power before and after going relatively strong."

The private person told reporters.

According to the industry analysts of CIC securities and Donghai securities, the good fundamentals of Kang Bei Bei are still the basis for the performance of the two tier market.

The company's annual report shows that net profit attributable to shareholders of listed companies increased 83.30% from 2010 to 0.56 yuan per share.

At the same time, the company also offered a dividend plan of 10 yuan, 2 pfers, 8 shares and 1 yuan.

In the first quarter of this year, the net profit of Kang Bei Bei staged another 229.95% year-on-year growth.

In the meantime, the private sector believes that the emergence of a good rhythm is an important reason for the continued strength of the company.

In February 22nd of this year, 19.5% of 300181.SZ was successfully landed on the gem. According to its 19 million 130 thousand yuan share cost, corresponding to the 23.5 yuan issue price of Zuoli pharmaceutical company, the 15 million 600 thousand stock market value of Kang Bei was 367 million yuan.

Stimulated by the above news, the price of Kang Bei was launched from 18.51 yuan in February 23rd and climbed to 22.34 yuan after 15 trading days, or more than 20%.

At the time of the above good digestion, in April 6th, Kang Bei sent a good news of a quarterly increase of over 200%, plus the temptation of sending ten to ten. In the 12 trading days, the shares of Kang and Bei quickly hit 27.55 yuan high from the 21 yuan position.

After the removal of power in April 25th, he was still good.

In May 18th, the company announced that the six class of new drugs, Huang Huang capsule, was successfully passed the examination and received the new drug certificate issued by the State Food and drug administration.

Data show that Huang Er capsule is a traditional Chinese medicine for prostatic hyperplasia, and prostate medicine is one of the most important sources of profit.

In fact, the day before the announcement of the good news, there were funds to intervene in the first place. On the same day, the board of directors of the company bought a blackout report. The big intelligence super win data showed that the main purchase of the stock was 0.26% of the total.

The tiger list data showed that the top five buyers were the Ministry of hot money business. The first place was the Jinhua Jinhua CITIC Securities Sales Department, which was the same place as Kang Bei Bei, and the purchase amount was $25 million 460 thousand and 600.

Reporters found that the good news again led to the rapid increase in the price of Kang's shell, rising from 11.45 yuan in May 16th to 14.15 yuan after three trading days.

The three big positive and orderly launch, along with the three strong upside, seems to have found a good medicine to stand up in the two tier market.

But what worries the private sector is how long can it take to rely on the support of hot money?

It is noteworthy that although there are only a few institutions in the top ten tradable shares, there are still signs of withdrawal.

In May 19th, it increased by 7.36%. On the same day, the top five buyers were all the Sales Department of the hot money business, while the first five of them sold an institutional seat with a selling amount of 23 million 6 thousand and 800 yuan.

Unlike the agencies taking the opportunity to run away, hot money still chooses to stick to it.

In May 31st, it was strong again, and the top five in the day were the hot money business department.

Among them, the mysterious CITIC golden pass securities Jinhua Zhongshan Road business department again came on the list, and ranked 23 million 722 thousand and 600 in the second place.